AHC Price sensitive 1 Jun 2026, 9:10 AM

FY26 Trading Update

Austco Healthcare Ltd

Austco Healthcare FY26 Trading Update

Key points

  • Revenue expected between $90 million to $95 million, up 11% to 17%
  • EBITDA expected between $14.0 million to $14.6 million, up 7% to 12%
  • Net profit after tax expected between $9.0 million to $9.4 million, up 52% to 58%

Full summary

Austco Healthcare Limited (ASX: AHC) has provided a trading update for the financial year ending 30 June 2026 (FY26). The company expects revenue to be between $90 million and $95 million, up 11% to 17% from FY25. EBITDA is forecasted to be between $14.0 million and $14.6 million, up 7% to 12%, with an EBITDA margin of approximately 15.5%. Net profit after tax is expected to be between $9.0 million and $9.4 million, up 52% to 58% from FY25. The company also expects a gross margin of around 52.8%. Key highlights include a major US rollout of Pulse Mobile and continued sales momentum across all regions, with new contract wins in New Zealand, Australia, Canada, and the United States.

Guidance

Revenue: $90m - $95m, EBITDA: $14.0m - $14.6m, Net profit after tax: $9.0m - $9.4m

Outlook

Austco expects to deliver another year of profitable growth in FY26, with revenue, earnings, and margins all ahead of the prior year. The company is successfully navigating tougher trading conditions and expects to enter FY27 with a healthy sales pipeline and continued momentum across all regions.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in